SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart ($UPST) is trending amidst discussions around its Q3 earnings and future prospects; while some express concerns about the company's business model and potential risks related to loan performance, others point to positive growth metrics and potential for a short squeeze. Community members are debating whether the recent price action reflects market manipulation or genuine concerns about the company's fundamentals, particularly in light of broader economic uncertainties and the performance of comparable fintech companies. The stock's high short interest and upcoming earnings are fueling speculation about a potential squeeze.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk ($NVO) is trending as the community discusses the ongoing bidding war with Pfizer for Metsera, with some questioning the aggressive pursuit given NVO's existing pipeline and others speculating about potential impacts on competition. Community members are also analyzing recent earnings and forward guidance, weighing the potential of upcoming FDA approvals against concerns about management strategy and competition from Eli Lilly.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software ($U) is trending amid discussions about its recent earnings report and future growth potential, especially regarding its Vector AI platform. The community is weighing the company's prospects against competitors and debating whether its current valuation reflects its potential, particularly in the ad tech and gaming sectors. Some investors believe Unity is undervalued and poised for significant growth under its new leadership, while others remain cautious.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

SLAP is trending as the community rallies around the meme coin, emphasizing its resilience and strong community. Talk centers around the coin's ability to hold strong despite market liquidations, with participants highlighting the coin's real-world partnerships and sponsorships. The community uses the phrase "that slaps" to express excitement and are focused on onboarding new users to crypto through IRL events.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as investors digest its latest earnings report, focusing on revenue growth and reaffirmation of the R2 launch timeline. Community discussions revolve around the company's progress in scaling production and managing costs, as well as its potential in AI and robotics. Bullish sentiment is fueled by positive reports despite existing concerns about cash flow and competition in the EV sector.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amidst discussions around election results and their potential impact on Trump's political influence and the stock's future. Community members are debating the implications of recent political outcomes and commenting on the stock's valuation, which appears heavily influenced by sentiment rather than fundamentals. The stock's high volatility and sensitivity to political events continue to drive conversation.

Digital Turbine, Inc. is a mobile growth platform that offers solutions for advertisers, publishers, carriers, and device original equipment manufacturers (OEMs). The firm operates through the On Device Solutions (ODS) and App Growth Platform (AGP) segments. The ODS segment generates revenue from the delivery of mobile application media or content to end users with solutions for all participants in the mobile application ecosystem that want to connect with end users and consumers who hold the device. This includes mobile carriers and device OEMs that participate in the app economy, app publishers and developers, and brands and advertising agencies. The AGP segment provides platforms that allow mobile app publishers and developers to monetize their monthly active users via display, native, and video advertising. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbine is trending as investors discuss its growth acceleration and potential as a hedge against market inflation. Community members are highlighting the company's international expansion and adoption of AI, with some suggesting a significant stock price increase in the coming months. Bullish sentiment is fueled by the company's potential to capitalize on the expanding market for mobile app distribution and advertising solutions.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is trending due to community discussion around a potential buyout offer from Nestle following recent financial results and business updates; the lack of confirmation from the company regarding buyout rumors is fueling speculation and frustration, as investors debate the likelihood of a deal versus a partnership or other strategic alternatives. Disappointment from a recent conference call has also added to investor unease, as some feel management danced around key questions about rumors of a buyout offer and future capital needs.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending as investors discuss its potential following a DA Davidson rating upgrade to Buy with a price target of 27. The community highlights the company's consistent beat and raise quarters, potential for analyst upgrades, and undervaluation. Traders are also noting increased volume and watching key support and resistance levels.

DigitalOcean Holdings, Inc. engages in the provision of providing cloud infrastructure. It operates through the following geographical segments: United States, Netherlands, Germany, Canada, Singapore, and Other. The company was founded in 2012 and is headquartered in Broomfield, CO.

DigitalOcean Holdings Inc

DigitalOcean is trending following positive earnings reports and future guidance, sparking bullish sentiment among investors. The community is focused on the company's growth in AI and its potential to compete with larger cloud providers. Discussions also include speculation about potential acquisitions and partnerships, particularly with AMD, driving further interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IQV &quot;Heads up alert! Only three days until Upcoming earnings on Tuesday, 10/28/2025 for $IQV 
Neutral (5.8) 
 
--- 
 
In recent evaluations of IQVIA Holdings (IQV), the company has demonstrated a mixed financial landscape characterized by both positive growth indicators and prevailing industry challenges. 
The stock has experienced a notable increase of approximately 39.8% over the past six months, outperforming the S&amp;P 500 by 11.8%. 
Currently, IQV trades around $200.20, with a consensus analyst price target rising slightly to $223, reflecting a cautious optimism about its operational stability and diversified service offerings. 
Key financial metrics reveal a P/E ratio of approximately 25, which is competitive within the healthcare analytics sector, though slightly above the industry average of around 22. 
Additionally, IQV&#39;s recent earnings per share (EPS) growth has shown promise, with projections indicating steady single-digit increases in profitability. 
Revenue forecasts suggest continued strength driven by biopharma services, despite headwinds related to the offloading of COVID-related inventories. 
Comparatively, IQVIA&#39;s performance is solid, although it has not fully matched the growth rates of some industry peers that are capitalizing on emerging market trends. 
Looking ahead, IQVIA is set to announce its Q3 earnings on October 28, 2025, with analysts expecting revenues and EPS to rise, driven by effective cost controls and biopharma strength. 
Historical performance indicates that IQV has a mixed track record of beating estimates, which could influence market sentiment post-announcement. 
The consensus among analysts remains cautiously optimistic, with a buy rating prevailing, although concerns about the broader healthcare sector&#39;s performance, which has trailed the S&amp;P 500, may temper expectations. 
The healthcare sector overall has returned 13.5% over the past six months, significantly lagging the S&amp;P 500 by 9.4 percentage points, indicating a challenging environment for companies like IQV that are navigating operational pressures while seeking growth opportunities. 
 
- Funds were net buyers of $IQV during the previous reporting quarter. 
 
- Funds with large holdings in $IQV include: 
 
- Canada Pension , MV: $657MM. Fund Rank: 78% 
 
- Farallon Capital Management LLC, MV: $607MM. Fund Rank: 70% 
www.faralloncapital.com 
- Cantillon Captal Management LLC, MV: $239MM. Fund Rank: 76% 
www.cantillon.com 
- Alyeska Investments, MV: $118MM. New position. Fund Rank: 79% 
 
- Cadian Capital Management LP, MV: $103MM. Fund Rank: 87% 
www.cadiancap.com 
- Last 10 days performance: 8% 
- Last 30 days performance: 22% 
- Last 90 days performance: 11% 
 
Some of the latest news articles: 
 - Title: 3 Healthcare Stocks Walking a Fine Line 
Publication Date: 10/24/2025 4:39:44 AM, Source: yahoo 
URL: https://finance.yahoo.com/news/3-healthcare-stocks-walking-fine-043944631.html?.tsrc=rss 
 
 - Title: IQVIA Gears Up to Report Q3 Earnings: What&#39;s in the Cards? 
Publication Date: 10/23/2025 2:19:00 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/iqvia-gears-report-q3-earnings-141900716.html?.tsrc=rss 
 
 - Title: What Catalysts Could Shift the Narrative for IQVIA Amid New Analyst Insights and Partnerships 
Publication Date: 10/23/2025 7:13:00 AM, Source: yahoo 
URL: https://finance.yahoo.com/news/catalysts-could-shift-narrative-iqvia-071300008.html?.tsrc=rss 
 
 - Title: TransMedics (TMDX) Reports Next Week: Wall Street Expects Earnings Growth 
Publication Date: 10/22/2025 2:00:33 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/transmedics-tmdx-reports-next-week-140033829.html?.tsrc=rss 
 
Follow us on stocktwits.com for more earnings alerts. Not a financial advice. Not a trading signal.&quot;

We pursue multiple investment strategies on an opportunistic basis.

Faralloncapital

Farallon Capital Management, L.L.C.

Cantillon

Default : Cantillon

Cadian Capital Management (Cadian) is a global long/short equity manager that invests across technology, media, telecommunications, healthcare, industrials, retail, consumer, and other related sectors.

Cadian Capital

Cadian Capital Management

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry's 13.5% return has trailed the S&P 500 by 9.4 percentage points.

Yahoo Finance

3 Healthcare Stocks Walking a Fine Line

IQV readies its Q3 report, with revenues and EPS expected to rise on biopharma strength and cost control despite muted beat odds.

IQVIA Gears Up to Report Q3 Earnings: What's in the Cards?

IQVIA Holdings has seen its consensus analyst price target rise slightly to $223 from $218, reflecting a modest uptick in projected fair value. Analysts link this change to confidence in the company's improving operational stability, reduced client risk exposure, and its diversified technology and analytics offerings.

What Catalysts Could Shift the Narrative for IQVIA Amid New Analyst Insights and Partnerships

TransMedics (TMDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TransMedics (TMDX) Reports Next Week: Wall Street Expects Earnings Growth

Stocktwits provides real-time stock, crypto & international market data to keep you up-to-date. Find top news headlines, discover your next trade idea, share & gain insights from traders and investors from around the world, build a watchlist, buy US stocks, & create and manage your portfolio.

Stocktwits

Stocktwits - Stock Market Live Quotes, Social Community Discussions, News, Stock Rankings & Earnings

StockTwits Web

IQVIA Holdings Inc

 "Heads up alert! Only three days until Upcoming earnings on Tuesday, 10/28/2025 for 

 
Neutral (5.8) 
 
--- 
 
In recent evaluations of IQVIA Holdings (IQV), the company has demonstrated a mixed financial landscape characterized by both positive growth indicators and prevailing industry challenges. 
The stock has experienced a notable increase of approximately 39.8% over the past six months, outperforming the S&P 500 by 11.8%. 
Currently, IQV trades around $200.20, with a consensus analyst price target rising slightly to $223, reflecting a cautious optimism about its operational stability and diversified service offerings. 
Key financial metrics reveal a P/E ratio of approximately 25, which is competitive within the healthcare analytics sector, though slightly above the industry average of around 22. 
Additionally, IQV's recent earnings per share (EPS) growth has shown promise, with projections indicating steady single-digit increases in profitability. 
Revenue forecasts suggest continued strength driven by biopharma services, despite headwinds related to the offloading of COVID-related inventories. 
Comparatively, IQVIA's performance is solid, although it has not fully matched the growth rates of some industry peers that are capitalizing on emerging market trends. 
Looking ahead, IQVIA is set to announce its Q3 earnings on October 28, 2025, with analysts expecting revenues and EPS to rise, driven by effective cost controls and biopharma strength. 
Historical performance indicates that IQV has a mixed track record of beating estimates, which could influence market sentiment post-announcement. 
The consensus among analysts remains cautiously optimistic, with a buy rating prevailing, although concerns about the broader healthcare sector's performance, which has trailed the S&P 500, may temper expectations. 
The healthcare sector overall has returned 13.5% over the past six months, significantly lagging the S&P 500 by 9.4 percentage points, indicating a challenging environment for companies like IQV that are navigating operational pressures while seeking growth opportunities. 
 
- Funds were net buyers of 

 during the previous reporting quarter. 
 
- Funds with large holdings in 

 include: 
 
- Canada Pension , MV: $657MM. Fund Rank: 78% 
 
- Farallon Capital Management LLC, MV: $607MM. Fund Rank: 70% 


 
- Cantillon Captal Management LLC, MV: $239MM. Fund Rank: 76% 


 
- Alyeska Investments, MV: $118MM. New position. Fund Rank: 79% 
 
- Cadian Capital Management LP, MV: $103MM. Fund Rank: 87% 


 
- Last 10 days performance: 8% 
- Last 30 days performance: 22% 
- Last 90 days performance: 11% 
 
Some of the latest news articles: 
 - Title: 3 Healthcare Stocks Walking a Fine Line 
Publication Date: 10/24/2025 4:39:44 AM, Source: yahoo 
URL: 

 
 
 - Title: IQVIA Gears Up to Report Q3 Earnings: What's in the Cards? 
Publication Date: 10/23/2025 2:19:00 PM, Source: yahoo 
URL: 

 
 
 - Title: What Catalysts Could Shift the Narrative for IQVIA Amid New Analyst Insights and Partnerships 
Publication Date: 10/23/2025 7:13:00 AM, Source: yahoo 
URL: 

 
 
 - Title: TransMedics (TMDX) Reports Next Week: Wall Street Expects Earnings Growth 
Publication Date: 10/22/2025 2:00:33 PM, Source: yahoo 
URL: 

 for more earnings alerts. Not a financial advice. Not a trading signal."